NASDAQ: ENTX - Entera Bio Ltd.

Altı ay boyunca karlılık: -5.64%
Sektör: Healthcare

Promosyon programı Entera Bio Ltd.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures.

Daha fazla ayrıntı
Its other product candidate is GLP-2, which is in preclinical trial for the treatment of short bowl syndrome; and hGh for the GH deficiency. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

Выручка 0.000236
EBITDA -0.0112
Число акций ао 0.02901 млрд
P/S 109.63
P/BV 2.17
EV/EBITDA -0.9795
Цена ао 1.55
ISIN IL0011429839
Сайт https://www.enterabio.com
P/E 2144.95
Валюта usd
IPO date 2018-06-28
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Günlük fiyat değişimi: -0.5405% (1.85)
Haftalık fiyat değişimi: -4.32% (1.9231)
Aylık fiyat değişimi: -2.13% (1.88)
3 ayda fiyat değişimi: +10.18% (1.67)
Altı ayda fiyat değişimi: -5.64% (1.95)
Yıllık fiyat değişimi: +162.48% (0.701)
3 yılda fiyat değişimi: -62.3% (4.88)
5 yılda fiyat değişimi: -34.29% (2.8)
Yılbaşından bu yana fiyat değişimi: +162.86% (0.7)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 1352.38 1
P/BV 1.82 8
P/E 2144.95 1
EV/EBITDA -0.9348 0
Toplam: 4

Yeterlik

İsim Anlam Seviye
ROA, % -75.55 0
ROE, % -85.59 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.0439 10
Toplam: 9.6

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % -94.07 0
karlılık Ebitda, % -20.68 0
karlılık EPS, % -65.78 0
Toplam: 0
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Knoll Capital Management, LLC 3881879 10.94
TWO SIGMA SECURITIES, LLC 69441 0.2
Renaissance Technologies, LLC 57400 0.16
Geode Capital Management, LLC 17597 0.05
PNC Financial Services Group, Inc. 13000 0.04
HighTower Advisors, LLC 11830 0.03
Millennium Management LLC 10097 0.03
Morgan Stanley 1000 0
Group One Trading, L.P. 345 0
Royal Bank of Canada 200 0



Süpervizör İş unvanı Ödeme Doğum yılı
Ms. Miranda J. Toledano M.B.A. CEO & Director 418k 1977 (47 yıllar)
Dr. Hillel Galitzer M.B.A., Ph.D. Chief Operating Officer 296k 1978 (46 yıllar)
Ms. Dana Yaacov-Garbeli CPA Chief Financial Officer 193k 1983 (41 yıl)
Dr. Gregory Burshtein Ph.D. Chief of Research & Development 1976 (48 yıllar)

Adres: Israel, Jerusalem, Kiryat Hadassah Minrav Building - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.enterabio.com